TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
PRTA

Prothena Corporation plc

Healthcare · Biotechnology

8.50$ +2.7% vs. previous close Closing price · As of: Sep 17, 2026

Statements

Income Statement

Prothena Corporation plc (PRTA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 9.7 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement PRTA
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
51 1.6 1.1 28 1.0 0.8 0.9 201 54 91 135 9.7
57 58 120 135 101 51 75 82 6.7 221 3.6 3.7
51 1.6 1.1 28 -100 -50 0.9 201 54 91 135 6.0
38 58 120 135 101 51 75 82 136 221 223 135
19 23 41 48 42 36 39 46 50 62 67 59
58 82 161 183 144 36 114 129 185 282 290 191
-6.6 -80 -160 -155 -159 -86 -113 72 -132 -191 -155 -185
0.0 0.0 0.9 3.7 3.7 8.2 8.3 6.7 6.7
-6.3 -80 -159 -158 -156 -77 -111 72 -126 -160 -129 -201
0.8 0.7 1.1 -4.4 -0.5 0.4 -0.3 4.9 -8.7 -13 -6.6 43
-7.2 -81 -160 -153 -156 -78 -111 67 -117 -147 -122 -244
-5.9 -79 -157 -152 -153 -84 -106 79 -131 -160 -128 -197

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?